Diazepam Binding Inhibitor anticorps
Aperçu rapide pour Diazepam Binding Inhibitor anticorps (ABIN6567860)
Antigène
Voir toutes Diazepam Binding Inhibitor (DBI) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human DBI (NP_001171513.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IHC 1:50-1:200 IF 1:50-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Diazepam Binding Inhibitor (DBI)
-
Autre désignation
- DBI
-
Sujet
- This gene encodes diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. The protein is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrenal steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene.
-
Poids moléculaire
-
Observed_MW: 11kDa
Calculated_MW: 10kDa/11kDa/13kDa/14kDa/16kDa
-
ID gène
- 1622
-
UniProt
- P07108
Antigène
-